Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Ixekizumab (Primary)
- Indications Pityriasis rubra pilaris
- Focus Therapeutic Use
- 30 Apr 2018 Planned End Date changed from 31 Dec 2019 to 30 Nov 2019.
- 30 Apr 2018 Status changed from not yet recruiting to recruiting.
- 05 Apr 2018 New trial record